FIELD: chemistry.
SUBSTANCE: invention relates to a novel compound corresponding to the structural formula given below. In new connection corresponding to structure
X1 is a branched or unbranched C1-10alkyl, (CH2)s-NH-(CH2)t or (CH2)s-O-(CH2)t, where each of s and t independently represents integer from 1 to 5; each of n1 and p1 independently represents integers from 1 to 10; and each of R20 -R33 independently represents hydrogen, halogen or C1-6haloalkyl, wherein at least one of R20 -R33 is halogen.
EFFECT: compound can be used for treating a disease, or condition mediated by TNFα activity by administering a pharmaceutical composition containing said compound which is suitable for treating inflammatory diseases that can be mediated by FBXO3; such a disease can be a respiratory disorder or disease, such as acute or chronic bronchitis.
14 cl, 14 dwg, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DUAL-ACTING ANTIHYPERTENSIVE COMPOUNDS, METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS | 2008 |
|
RU2476427C2 |
N-7 SUBSTITUTED PURINES AND PYRAZOLOPYRIMIDINES, COMPOSITIONS THEREOF AND METHODS FOR USE | 2010 |
|
RU2515541C2 |
NEPRILYSIN INHIBITORS | 2011 |
|
RU2605557C2 |
INHIBITORS OF NONPRILYZINE | 2011 |
|
RU2622288C2 |
HIV-INHIBITING 5-AMIDO-SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2480464C2 |
ALDOSE REDUCTASE INHIBITORS AND METHODS OF THEIR APPLICATION | 2017 |
|
RU2795195C2 |
SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | 2012 |
|
RU2604522C2 |
USE OF IBAT INHIBITOR FOR TREATING AND PREVENTING CONSTIPATION | 2008 |
|
RU2482850C2 |
SUBSTITUTED 4-(ARYLAMINO) SELENOPHENOPYRIMIDINE COMPOUNDS AND METHODS OF THEREOF APPLICATION | 2011 |
|
RU2566293C2 |
COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING OR ELIMINATING BITTER TASTE | 2011 |
|
RU2597438C2 |
Authors
Dates
2020-02-10—Published
2015-12-10—Filed